The DIDB team will be exhibiting at the upcoming 18th International Conference on Drug-Drug Interactions in Seattle on June 29-July 1, 2014, and will contribute to the scientific program with two presentations:
* Critical Review of the 2014-2015 Literature (Dr. Sophie Argon)
* New Molecular Entities Approved by FDA in 2014: Review of In Vitro and In Vivo Data (Dr. Jingjing Yu)
Dr. Ragueneau-Majlessi will be chairing the session entitled “NDA and Literature Update” on June 29th.